2019.maculart-meeting.com€¦ · web viewcurricilum vitae. name. anat loewenstein, professor....

Saturday, May 20, 2023

CURRICILUM VITAE

NAME Anat Loewenstein, ProfessorEMPLOYMENT Tel Aviv Medical Center, Dept. of Ophthalmology

Ph.: +972 3 692 5773

HOME ADDRESS 18, Levy Eshkol street, apt. 73, Tel Aviv, 6936103, IsraelPh.: +972 3 699 6222

DATE OF BIRTH 4 July 1959

PLACE OF BIRTH Israel

MILITARY SERVICE 1984-1988, Physician in Navy Headquarters

MARITAL STATUS Married, 3 children

EDUCATION

1984 Medicine, MDHebrew University, Jerusalem, Israel

1995 Ophthalmology, Masters (with honors)Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelDissertation: " The significance of time interval between the topical instillation of two different ophthalmic drops."Supervisors: Prof. Orna Geyer and Prof. Moshe Lazar

2001 Health Administration, MHARecanati School of Business Administration, Tel Aviv University, Tel Aviv, Israel

ACADEMIC AND PROFESSIONAL EXPERIENCE

2000-Present Head of Department of OphthalmologyTel Aviv Medical Center, Tel Aviv, Israel

2006-Present Vice-Dean of Medical SchoolSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

2007-Present Full Professor of OphthamologySackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

2012-Present Incumbent, The Sydney A. Fox Chair in OphthalmologySackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

1999-2007 Associate Professor of OphthalmologySackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel


1998-1999 Senior Lecturer, OphthalmologySackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

1998-2000 Head of Vitreoretina service, Ophthalmology DepartmentTel Aviv Medical Center, Tel Aviv, Israel

1997-1998 Fellow Medical and Surgical Retina, Wilmer Institute, fellowshipJohn Hopkins University Hospital, Baltimore, MD, USA

1995-1997 Senior Lecturer, OphthalmologySackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

1995-1997 FacultyTel Aviv Medical Center, Tel Aviv, Israel

1993-1995 Lecturer, Ophthalmology Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

1991-1993 Instructor, OphthalmologySackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

1898-1994 Resident, OphthalmologyTel Aviv Medical Center, Tel Aviv, Israel

ACADEMIC AND PROFESSIONAL AWARDS

2017 Silver Fellow Medal of ARVO

2017 Michelson Award of the Macula Society

2016 The Ophthalmology Power list: Top 100

2016 Macula of Paris Award

2015 The Macula Society Arnall Patz Medal for outstanding contribution in studies of retinal and macular diseases

2011 The American Academy of Ophthalmology Best Poster Award

2010 The American Society of Retina Specialists Senior Honor Award for Outstanding Service to the Society Scientific and Educational Programs

2010 Certificate of Appreciation, University of Louisville

2009 Honors Award, Pan-Hellenic Vetreoretina Society

2008 Achievement Award, American Academy of Ophthalmology


2006 Senior Honor Award, American Society of Retina Specialists

2006 Rosenthal Award, Macula Society

2004 Honor Award, American Society of Retina Specialists

2003 fMRI in AMD, Macula Society

2002 Research Fair, Replacing the Amsler, Tel Aviv University

2002 AChE in Retina, Ministry of Health, Jerusalem, Israel

2000 AChE in Retina, Ministry of Health, Jerusalem, Israel

2000 AChE in Retina, Wasserman Foundation, Tel Aviv, Israel

1999 Perception in AMD, Ministry of Health, Jerusalem, Israel

1996 Fellowship Grant, Isabelle Zangvil Foundation

1996 RBCs in Diabetes, Ministry of Health, Jerusalem, Israel

1992 Gothulf Award, Tel Aviv University, Tel Aviv, Israel

1986 Albert Soulka Price, Hebrew University, Jerusalem, Israel

MEMBERSHIP IN PROFESSIONAL SOCIETIES

2018-Present Co-Chair ARVO Women's Leadership Development Program

2017-Present Executive Vice President EAO

2015-Present Euretina General Board Secretary

2015-Present Retina World Congress Board Member

2015-Present Academia Ophthalmology Internationalis Chairperson

2014-Present Bayer Academy Steering Committee

2014 European Academy of Ophthalmology (member XLIV)

2012 The Retina Society

2012 International Representative to the Macula Society executive Board

2010 European Society of Ophthalmology (SOE), Israeli Representative

2009-Present National Counsel for Surgery, Anesthetics & Intensive Care

2009-Present Club Jules Gonin


2003-Present Association for Clinical Research Practice (International)

2000-Present Macula Society (International)

1997-Present Vitreous Society (International)

1997-Present American Society of Retina Specialists (International)

1995-Present American Academy of Ophthalmology (International)Vice Chair of Knowledge Base Retina/Vitreous Panel

1992-Present Association for Research in Vision and Ophthalmology

1989-Present Israeli Ophthalmology Society

1988-Present Israeli Society for Research

DOCTORAL STUDENTS SUPERVISED, BY CANDIDATE

Year Name of Student

Subject of Thesis Institution

2017 Einat Shtal Heterologous overexpression of Retinoschisin involved in X-linked retinoschisis

Tel Aviv University

2017 Michal Goldenberg

Biochemical characterization of DHDDS: implications for retinitis pigmentosa

Tel Aviv University

2017 Ilan Edri Heterologous overexpression and purification of the enzyme DHDDS and its retinitis pigmentosa-causing mutation K42E

Tel Aviv University

2017 Meital Orenstein

Co culture of hypoxic organotypic retina with adipose derived mesenchymal stem cells

Tel Aviv University

2016 Dan Ramon Toxicity of Ziv Aflibercept to the rabbit retina Technion Haifa Faculty of Medicine

2013 Chaim Oz RNFL in glaucoma and diabetes Tel Aviv University

2008 Zvi Davidovitch Removal of ERM Tel Aviv University

2008 Oren Hanis The correlation between retinal disease and erection's dysfunction in diabetic men

Tel Aviv University

2006 Michael Kinori AVASTIN Tel Aviv University

2006 Ainat Klein Tonometers Tel Aviv University

2004 Michael Tonometer compared to Tonopen Tel Aviv University


Wissbroth

1999 Jonathan Levi Homocystein in AION Tel Aviv University

1999 Menashe Gabay

Trabeculectomy Technion Haifa

1998 Oren Bchor RTA in CME Tel Aviv University

1998 Udi Gerstein RTA in DM Tel Aviv University

1998 Tomer Kacwell Thrombocytopenia Tel Aviv University

1996 Guy Zeidman Excimer Laser Tel Aviv University

1995 Hana Genigstein

IOP in Excimer Laser Hebrew University of Jerusalem

1995 Kobi Zorani RK vs PRK Tel Aviv University

1995 Limor Herlin Vacomycin in closed lids Hebrew University of Jerusalem – Submitted

1994 Ayelet Brandt Astigmatism in Cataract Tel Aviv University

1994 Tami Baumwald

Dapiprazole for Glare Tel Aviv University – Published

1994 Florina Lichtenstein

Astigmatism in PRK Hebrew University of Jerusalem – Published

1994 Naama Yassur PRK in High Myopia Ben Gurion University Be'er Sheva

1994 Pazit Raz Asig & Amblyopia Tel Aviv University

1994 Barak Vered Bilateral PRK Tel Aviv University – Published

1993 Daniela Levanon

Age and PRK Hebrew University of Jerusalem – Published

1993 Yael Littman Acute Glaucoma during Gulf War Tel Aviv University

1993 Ayala Ben-Sira Patient Satisfaction after PRK Tel Aviv University – Published

1993 Kobi Rosenberger

Diapetes in hospitalized patients Tel Aviv University

1993 Ruth Holzman Fuchs & Angle Closure Glaucoma Tel Aviv University –


Published

1992 Usi Oppenheimer

Honan Balloon Tel Aviv University – Published

1992 Bruria Shalmon Dapiprazole Efficacy Tel Aviv University – Published

1991 Idit Gertler Adverse Reactions to Glaucoma Medicine Tel Aviv University – Published

1991 Sara Bolocinic Closed lids Tel Aviv University – Published

1991 Daphne Hourvitz

Fuchs & Angle Closure Glaucoma Tel Aviv University – Published

1991 Anat Blanc Drops Instillation Tel Aviv University – Published

1990 Roni Rahmiel Eye Donation Tel Aviv University – Published

OTHER:

Editor - Case Reports in Ophthalmology

Editorial board – Retina, European Ophthalmic Review, European Journal of Ophthalmology, Ophthalmologica, Graefes Archives for Clinical and Experimental Ophthalmology, Retinal Physician, European and US Ophthalmic Review, Retina Image Bank (ASRS), OSNE

Reviewer ad-hoc Ophthalmology, American Journal of Ophthalmology, Ophthalmic Surgery and Lasers, Investigative Ophthalmology and Visual Sciences

Member – Compass Panel (Retina/Vitreous), American Academy of Ophthalmology

Board member of Euretina

Consultant, Medical Advisory Board – Notal Vision, Ltd, Allergan, Inc, Novartis, Inc.

Head of the Ethics Committee of Israeli Ministry of Health

Member - National Council of Surgery

Member - National Committee for Operating Room Procedures and Operation

Chair, Alumni Association, Masters of Health Administration Program, Recanati Business School, Tel Aviv, Israel


Member of the Steering Committee, the Bayer Academy

SCIENTIFIC PUBLICATIONS

ORIGINAL ARTICLES

Published Articles

1) Victor Godel, Anat Loewenstein, Moshe Lazar.Spectral electroretinography in thioridazine toxicity.Ann Ophthalmol 1990; 22:293-6.

2) Anat Loewenstein, Roni Rahmiel, David Varssano, Moshe Lazar.Obtaining consent for eye donation.a. Isr J Med Sci 1991; 27:79-81.b. Year Book 1992; 248.

3) Anat Loewenstein, David Varssano, Moshe Lazar, Orna Geyer.Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical clonidine.a. Acta Ophthalmol 1991; 69:462-5.b. Current Opinion in Ophthalmology Feb. 1993.

4) Anat Loewenstein, Roni Rahmiel, David Varssano, Moshe Lazar.Obtaining consent for eye donation.Isr J Med Sci 1991; 27: 79-81.

5) Anat Loewenstein, Esther Zemel, Moshe Lazar, Ido Perlman.The effects of Depo-Medrol preservative on the rabbit visual system.Invest Ophthalmol Vis Sci 1991;32:3053-60.

6) Anat Loewenstein, Orna Geyer, Daphne Hourvitz, Moshe Lazar.The association of Fuch’s corneal endothelial dystrophy with angle closure glaucoma.Br J Ophthalmol 1991;75:510.

7) Anat Loewenstein, Anat Blanc, Orna Geyer, Moshe Lazar.Dosing problems in the use of topical ophthalmic drops.Arch Clin Exp Ophthalmol 1992; 230:378-9.

8) Chaim Stolovitch, Anat Loewenstein, Pinchas Nemmet, Moshe Lazar.The use of cyclopentolate vs. atropine in Caucasians.Binocular Vision 1992; 7:93-6.

9) Isaac Lipshitz, Yoram Mayron, Anat Loewenstein.Combined transverse and interrupted radial keratotomy for compound myopic astigmatism.Refract Corneal Surg 1992; 8:280-5.


10) Chaim Stolovitch, Anat Loewenstein, Pinchas Nemmet, Moshe Lazar.Atropine cycloplegia: How many instillations does one need?J Pediatr Ophthalmol Strabismus 1992; 29:175-6.

11) Orna Geyer, Yoram Meyron, Anat Loewenstein, Moshe Lazar.Tono-Pen tonometry in normal and in post-keratoplasty eyes.Br J Ophthalmol 1992; 76:538-40.

12) Orna Geyer, Anat Loewenstein, Idit Gertler-Hertz, Moshe Lazar.Acute systemic side-effects of topical for glaucoma.תופעות לוואי מערכתיות של תרופות מקומיות בגלאוקומהHarefuah 1992; 123:460-1.

13) Anat Loewenstein, Orna Geyer, Moshe Lazar.Intentional retention of Descemet’s membrane in keratoplasty for the surgical treatment of bullous keratopathy.a. Acta Ophthalmol 1993; 71:280-2.b. Current Opinion in Ophthalmology 1993.

14) Esther Zemel, Anat Loewenstein, Moshe Lazar, Ido Perlman.The effects of myristyl gamma-picolinium chloride on the rabbit retina: morphologic observations.Invest Ophthalmol Vis Sci 1993; 34:2360-6.

15) Isaac Lipshitz, Anat Loewenstein, Moshe Lazar.Excimer laser correction of myopia.אקסימר לייזר לתיקון קוצר ראייהHarefuah 1993;125:4-6.

16) Irith Reider-Grosswasser, Anat Loewenstein, Vera Feiler-Offry, Victor Godel, Ofer Merimsky, Dan D. Gaton, Moshe Lazar.Orbital non-Hodgkin lymphoma: Computerized tomography study in 7 patients.Diag Oncology 1992; 2:318-2.

17) Anat Loewenstein, Esther Zemel, Moshe Lazar, Ido Perlman.Drug-induced retinal toxicity in albino rabbits: the effects of imipenem two and aztreonam.Invest Ophthalmol Vis Sci 1993; 34:3466-76.

18) Pinchas Nemmet, Chaim Stolovitch, Anat Loewenstein.Slanted horizontal muscle surgery for convergence excess esotropia.Binocular Vision 1993; 8:241-8.

19) Anat Loewenstein, Victor Godel, Liat Godel, Moshe Lazar.Variable phenotypic expressivity of Best’s vitelliform dystrophy.Ophthalmic Paediatr Genet 1993; 14:131-6.

20) Anat Loewenstein, Isaac Lipshitz, Moshe Lazar.Scrapping of epithelium for treatment of undercorrection and haze after PRK.J Refract Corneal Surg 1994; 10:S274-6.


21) Michaela Goldstein, Anat Loewenstein, Mordechai Rosner, Isaac Lipshitz, Moshe Lazar.Phototherapeutic keratectomy in the treatment of corneal scarring from trachoma.J Refract Corneal Surg 1994; 10:S290-2.

22) Isaac Lipshitz, Anat Loewenstein, Moshe Lazar.Astigmatic keratotomy followed by PRK in the treatment of compound myopic astigmatism.J Refract Corneal Surg 1994; 10:S282-4.

23) Anat Loewenstein, Sarah Bolocinic, Michaela Goldstein, Moshe Lazar.Application of eye drops to the medial canthus.Graefes Arch Clin Exp Ophthalmol 1994; 232:680-2.

24) Anat Loewenstein, Alon Sadeh, Michaela Goldstein, Moshe Lazar.The effect of nasolacrimal occlusion on drug induced mydriasis.Graefes Arch Clin Exp Ophthalmol 1994; 233:530-1.

25) Chaim Stolovitch, Yair Alster, Anat Loewenstein, Moshe Lazar.Influence of the time interval between instillation of two drops of cyclopentolate 1% on refraction and dilation of the pupil in children.Am J Ophthalmol 1995; 119:637-9.

26) Esther Zemel, Anat Loewenstein, Bo Lei, Moshe Lazar, Ido Perlman.Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity.Invest Ophthalmol Vis Sci 1995; 36:1875-84.

27) Esther Zemel, Anat Loewenstein, Moshe Lazar, Ido Perlman.The effects of lidocaine and bupivacaine on the rabbit retina.Doc Ophthalmol 1995; 90:189-9.

28) Anat Loewenstein, Isaac Lipshitz, Florina Lichtenstein, Ayala Ben-Sira, Moshe Lazar.The effect of spherical PRK on myopic astigmatism.J Refract Surg 1995; 11:S263-4.

29) Anat Loewenstein, Isaac Lipshitz, Ayala Ben-Sira, Vered Barak, Moshe Lazar.Symmetry of outcome after PRK for myopia.J Refract Surg 1995; 11:S268-9.

30) Orna Geyer, Anat Loewenstein, Bruria Shalmon, Meira Neudorfer, Moshe Lazar.The additive miotic effects of dapiprazole and pilocarpine.Graefes Arch Clin Exp Ophthalmol 1995; 233:448-51.

31) Yuval Yassur, Irit Rosenblatt, Anat Loewenstein.Grid laser photocoagulation on decompensated retinal pigment epithelium:


adjunct treatment of choroidal neovascularization.MEJO 1995; 3:77-83.

32) Elizabeth Engle, Ivonne Marondel, William Houtman, Berendina de Vries, Anat Loewenstein, Moshe Lazar, DC Ward, R Kucherlapati, Allen Beggs.Congenital fibrosis of the extraocular muscles (autosomal dominant congenital external ophthalmoplegia): genetic homogeneity, linkage refinement and physical mapping on chromosome 12.Am J Human Genet 1995; 57:1086-94.

33) Irit Rosenblatt, Shimon Weitzman, Yuval Yassur, Linda Zangwill, Anat Loewenstein.Detection of diabetic retinopathy: a tracer for evaluating health services for non-insulin dependent diabetes mellitus patients.MEJO 1995; 3:156-60.

34) Isaac Lipshitz, Rephael Bass, Anat Loewenstein.Cutting the cornea with a waterjet keratome.J Refract Surg 1996; 12:184-6.

35) Yair Alster, Anat Loewenstein, Tami Baumwald, Isaac Lipshitz, Moshe Lazar.Dapiprazole for patients with night haloes after excimer keratectomy.Graefes Arch Clin Exp Ophthalmol 1996; 234:S139-41.

36) Dani D Gaton, Anat Loewenstein, Ofer Merimsky, Moshe Lazar, Irith Reider-Groswasser.Empty Sella.Radiography 1996; 2:215-1.

37) Dida Kazakova, Anat Loewenstein, Rivka Bracha, Moshe Lazar.Screening for diabetic retinopathy in hospitalized patient.Bulgarian Journal of Ophthalmology 1996; 1:6-8.

38) Anat Loewenstein, Irit Rosenblatt, Yuval Yassur.Interferon for age-related macular degeneration.אינטרפרון לטיפול בניוון הרשתית הקשור לגילHarefuah 1997; 132:275-9.

39) Ayala Ben-Sira, Anat Loewenstein, Isaac Lipshitz, Daniela Levanon, Moshe Lazar.Patient satisfaction after 5.0-mm photorefractive keratectomy for myopia.J Refract Surg 1997; 13:129-34.

40) Isaac Lipshitz, Anat Loewenstein, David Varssano, Moshe Lazar.Late onset corneal haze after PRK for moderate and high myopia.Ophthalmology 1997; 104:369-73.

41) Anat Loewenstein, Isaac Lipshitz, Daniela Levanon, Ayala Ben-Sirah, Moshe Lazar.Influence of patient age on photorefractive keratectomy for myopia.J Refract Surg 1997; 13:23-6.


42) Anat Loewenstein, Isaac Lipshitz, David Varssano, Moshe Lazar.Excimer laser reablation.a. Ophthalmic Surg Lasers 1997; 28:282-7;b. Yearbook of Ophthalmology 1998;54.

43) Isaac Lipshitz, Anat Loewenstein, Meir Reingewirtz, Moshe Lazar.An intraocular telescopic lens for macular degeneration.Ophthalmic Surg Lasers 1997; 28:513-7.

44) Anat Loewenstein, Scott Rader, Terry Shelley, Eugene de Juan Jr.A flexible infusion micro-cannula for subretinal surgery.Ophthalmic Surg Lasers 1997; 28:774-5.

45) Anat Loewenstein, Isaac Lipshitz, David Varssano, Moshe Lazar.Complications of excimer laser photorefractive keratectomy for myopia.J Cataract Refract Surg 1997; 23:1174-6.

46) Isaac Lipshitz, Lilian Fisher, Moshe Lazar, Anat Loewenstein.Epithelial cell adhesion and haze after photorefractive keratectomy.J Refract Surg 1997; 13:S451.

47) Anat Loewenstein, Andrew Lamborne, Julia Haller, Eugene de Juan Jr.Effect of scleral indentation on diode laser transscleral retinal photocoagulation.Ophthalmic Surg Lasers 1998; 29:658-62.

48) Chaim Stolovitch, Yair Alster, Michaela Goldstein, Anat Loewenstein, Moshe LazarApplication of cyclopentolate 1% to the medial canthus in children.J Pediatr Ophthalmol Strabismus 1998; 35:182-4.

49) Laura B. Enyedi, Anat Loewenstein, Eugene de Juan, Jr.The effect of intraocular pressure on the absorption of air from the vitreous cavity.Graefes Arch Clin Exp Ophthalmol 1998;236:301-4.

50) Kazuyuki Imai, Anat Loewenstein, Eugene de Juan, Jr.Translocation of the retina for management of subfoveal choroidal neovascularization I: experimental studies in the rabbit eye.Am J Ophthalmol 1998; 125:627-34.

51) Eugene de Juan, Jr., Anat Loewenstein, Neil Bressler, Judith Alexander.Translocation of the retina for management of subfoveal choroidal neovascularization. II: a preliminary report in humans.Am J Ophthalmol 1998; 125:635-46.

52) Anat Loewenstein, Janet S. Sunness, Neil M. Bressler, Marta J Marsh, Eugene de Juan, Jr.Scanning laser ophthalmoscope fundus perimetry after surgery for choroidal neovascularization.


Am J Ophthalmol 1998; 125:657-65.53) Yair Alster, Anat Loewenstein, Shlomo Levin, Moshe Lazar, Rafi Korenstein.

Low-frequency submicron fluctuations of red blood cells in diabetic retinopathy.Arch Ophthalmol 1998; 116:1321-5.

54) Chaim Stolovitch, David Varssano, Moshe Lazar, Anat Loewenstein.Untreated anisometropia and normal stereoacuity.Ann Ophthalmol 1998; 30:142-4.

55) Isaac Lipshitz, Lili Fisher, Moshe Lazar, Anat Loewenstein.Bilateral comparison of photorefractive keratectomy for myopia using two excimer lasers.J Refract Surg 1999; 15:334-7.

56) Isaac Lipshitz, Lilian Fisher, Moshe Lazar, Anat Loewenstein.Comparison of photorefractive keratectomy on one eye and laser in situ keratomileusis on the other eye of the same patient.J Refract Surg 1999; 15:S225-6.

57) Ron S. Broide, Mirta Grifman, Anat Loewenstein, Dan Grisaru, Rina Timberg et al.Manipulations of ACHE gene expression suggest non-catalytic involvement of acetylcholinesterase in the functioning of mammalian photoreceptors but notin retinal degeneration.Brain Res Mol Brain Res 1999; 71:137-48.

58) Anat Loewenstein, Michaela Goldstein, Asher Winder, Moshe Lazar, Amiram Eldor.Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation.Ophthalmology 1999; 106:1817-20.

59) Kazuyuki Imai, Anat Loewesntein, Barba Koroma, Rhonda Grebe, Eugene de Juan.Herbimycin A in the treatment of experimental proliferative vitreoretinopathy: toxicity and efficacy study.Graefes Arch Clin Exp Ophthalmol 2000;238:440-7.

60) Anat Loewenstein, Shiri Shulman, Moshe Lazar.Ocular injuries caused by elastic cords.Isr Med Assoc 1999; 1:287-8.

61) Anat Loewenstein, Mark Humayun, Eugere de Juan, Jr., Peter Campochiaro, Julia Haller.Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery.Ophthalmology 2000; 107:1078-82.

62) Pazit Pianka, Yehoshua Almog, Oran Man, Michaela Goldstein, Ben-Ami Sela, Anat


Loewenstein.Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion.Ophthalmology 2000; 107:1588-92.

63) Yair Alster, Limor Herlin, Moshe Lazar, Anat Loewenstein.Intraocular penetration of vancomycin eye drops after application to the medial canthus with closed lids.Br J Ophthalmol 2000; 84:300-2.

64) Isaac Lipshitz, Alon D Sadeh, Anat Loewenstein.The implantable miniaturized telescope for patients with age-related macular degeneration: design and surgical technique.Operative Techniques in Cataract and Refractive Surgery 2000; 3:1-7.

65) Anat Loewenstein, Irina Barequet, Eugene de Juan, Irene Maumenee.Retinal detachment in Marfan syndrome.Retina 2000; 20:358-63.

66) Anat Loewenstein, Esther Zemel, Yaffa Vered, Moshe Lazar, Ido Perlman.Retinal toxicity of gentamicin after subconjunctival injection performed adjacent to thinned sclera.Ophthalmology 2001;108:759-64.

67) Isaac Lipshitz, Oran Man, Shemesh G, Moshe Lazar, Anat Loewenstein.Laser in situ keratomileusis to correct hyperopic shift after radial keratotomy.J Cataract Refract Surg 2001;27:273-76.

68) Alon Sadeh, Gad Dotan, Rivka Bracha, Moshe Lazar, Anat Loewenstein.Characteristics and outcomes of paediatric rhegmatogenous retinal detachment treated by segmental scleral buckling plus an encircling element.Eye 2001;15:31-3.

69) Rotstein R, Zeltser D, Shapira I, Avitzour D, Fusman R, Dvolatzki T, Anat Loewenstein, Aronson V, Bornstein N, Nadie Arber, Shlomo Berliner.The usefulness of an inflammation meter to detect the presence of infection/Inflammation in elderly patients.J Gerontol A Biol Sci Med Sci 2002;57:M122-7.

70) Meira Neudorfer, Igal Leibovitch, Amir Onn, Anat Loewenstein, Elizabeth Fireman.Induced sputum for identifying sarcoidosis in patients with uveitis.Ophthalmology 2002;109:858-61.

71) Chaim Stolovitch, Igal Leibovitch, Anat Loewenstein.Long-term results of superior oblique tendon elongation for Brown’s syndrome.J Pediatr Ophthalmol Strabismus 2002;39:90-3.

72) Anat Loewenstein, Rafael Malach, Michaela Goldstein, Igal Leibovich, Adiel Barak, Eli Baruch, Yair Alster, Omer Rafaeli, Isaac Avni, Yuval Yassur.Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration.


Ophthalmology 2003;110;966-70.

73) Igal Leibovitch, Yair Alster, JM Schermann, Barak Azmon, Irina Barequet, Arieh Livneh, Terrie O’Brien, Moshe Lazar, Anat Loewenstein.Colchicine in tear fluid of treated patients with familial Mediterranean fever.Cornea 2003;22:191-3.

74) David Varssano, Adi Michaeli-Cohen, Anat Loewenstein.Excision of pterygium and conjunctival autograft.Isr Med Assoc J 2002;4:1097-1100.

75) Simon Kurtz, Igal Leibovitch, Gabi Shemesh, Levi Rothkoff, Anat Loewenstein.The effect of latanoprost on accommodation in young patients with ocular hypertension.J Glaucoma 2003;12:54-6.

76) Igal Leibovitch, Simon Kurtz, Gabi Shemesh, Michaela Goldstein, Ben Ami Sela, Anat Loewenstein.Hyperhomocystinemia in pseudoexfoliation glaucoma.J Glaucoma 2003;12:36-9.

77) Simon Rumelt, Igor Kaiserman, Uri Rehany, Avinoam Ophir, Josef Pikkel, Anat Loewenstein.Detachment of subfoveal choroidal neovascularization in age-related macular degeneration.Am J Ophthalmol 2002;134:822-7.

78) Koki Yamada, Caroline Andrews, Wai-Man Chan, Craig McKeown, Adriano Magli, Teresa de Berardinis, Anat Loewenstein, Moshe Lazar, Michael O’Keefe, et al.Heterozygous mutations of the kinestin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1).Nat Genet 2003;35:318-21.

79) Yoram Lerner, Pazit Pianka, Barak Azmon, Hana Leiba, Chaim Stolovitch, Anat Loewenstein, Michal Harel, Talma Hendler, Rafael Malach.Area-specific amblyopic effects in human occipitotemporal object representations.Neuron 2003;40:1023-9.

81) Igal Leibovitch, Anat Loewenstein, Yair Alster, Irit Rosenblatt, Moshe Lazar, Yuval Yassur, Ardon Rubinstein.Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment.Ophthalmic Surg Lasers Imaging 2004;35:16-22.

82) Michaela Goldstein, Igal Leibovitch, David Varssano, Levi Rothkoff, Natan Feitt, Anat Loewenstein.Axial length, refractive error, and keratometry in patients with branch retinal vein occlusion.Eur J Ophthalmol 2004;13:37-9.


83) Michaela Goldstein, Igal Leibovitch, Irina Yeffimov, Simon Gavendo, Ben Ami Sela, Anat Loewenstein.Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy.Eye 2004;18:460-5.

84) Michaela Goldstein, Gadi Heilweil, Adiel Barak, Anat Loewenstein.Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD.Eye 2005;19:1315-24.

85) Michaela Goldstein, Igal Leibovitch, Shlomo Levin, Yair Alster, Anat Loewenstein, Gabi Malkin, Rafi Korenstein.Red blood cell membrane mechanical fluctuations in non-proliferative and proliferate diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol 2004; 242:937-43.

86) Dror Zur, Guy Ben Simon, Anat Loewenstein, Yair Alster, Joseph Moisseiev, Simon Ullman.A novel high-resolution kinetic method for visual field mapping of scotoma in age-related macular degeneration.Ophthalmic Surg Lasers Imaging 2004;35:395-405.

87) Michaela Goldstein, Anat Loewenstein, Adiel Barak, et al.; Preferential Hyperacuity Perimeter Research Group.Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration.Retina 2005;25:296-303.

88) PHP research Group.The preferential hyperacuity perimeter for detection of choroidal neovascularization.Ophthalmology 2005;112:1758-65.

89) Michaela Goldstein, Anat Loewenstein, Esther Zemel, Ido Perlman.Retinal toxicity of Indocyanine Green in albino rabbits.Investigative Ophthalmology & Visual Science 2006;47:2100-7.

90) Adiel Barak, Anat Kesler, Daniel Gold, Anat Loewenstein.Visual field defects after radial optic neuropathy for central retinal vein occlusion.Retina 2006;26:549-54.

91) Yonathan Shahar, Robert Avery, Gad Heilweil, Adiel Barak, Geoff Lewis, Steve Fischer, Esther Zemel, Ido Perlman, Anat Loewenstein.Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin)..Retina 2006;26:262-9.

92) Adiel Barak, Michael Roegenbogen, Michaela Goldstein, Anat Loewenstein. Intravitreal triamcinolone for refractory diabetic macular edema.


Isr Med Assoc J 2006;8:83-7.

93) Tamara Wygnanski-Jaffe, Howard Desatnik, Amir Alhalel, Ricki Zolf, Michaela Goldstein, Anat Loewenstein, Ricki Zolf, Joseph Moisseiev.ICG guided photodynamic therapy for large pigment epithelium detachment in age related macular degeneration. Ophthalmic Surg Lasers Imaging 2006;37:358-63.

94) Anat Loewenstein, Michaela Goldstein.Intravitreal triamcinolone acetonide for diabetic macula edema.Isr Med Assoc J 2006;8:426-7.

95) Anat Loewenstein, Michaela Goldstein.The role of the ophthalmologist in educating the diabetic patient.Isr Med Assoc J 2006;8:568-9.

96) Michael Waisbourd, Anat Rabinovitch, Gadi Heilweil, Michaela Goldstein, Anat Loewenstein.Awareness and the use of nutritional supplementation for age-related macular degeneration patients.Eye 2007;21:998-9.

97) Anat Loewenstein, Richard & Hinda Rosenthal Foundation.The significance of early detection of age-related macular degeneration: Richard & Hinda Rosenthal Foundation lecture, The Macula Society 29th annual meeting.Retina, 2007; 27:873-878.

98) Micael Waisbourd, Anat Loewenstein.About genetics, lifestyle and age-related macular degeneration.Isr Med Assoc J 2007;9:674-675.

99) Shiri Zayit-Soudry, Michal Alfasi, Michaela Goldstein, Joseph Moisseiev, Ruti Axer-Siegel, Ayala Pollack, Yuval Yassur, Anat Loewenstein.Variability among retina specialists in evaluating fluorescein angiograms of patients with neovascular age-related macular degeneration.Retina 2007;27:798-803.

100) R. Kehat, Esther Zemel, N. Cuenca, T. Evron, D. Toiber, Anat Loewenstein, Hermona Soreq, Ido Perlman.A novel isoform of acetylcholinesterase exacerbates photoreceptors death after photic stress.Invest Ophthalmol Vis Sci 2007;48:1290-7.

101) Michael Waisbourd, Anat Loewenstein, Michaela Goldstein, Igal Leibovitch.Targeting vascular endothelial growth factor: a promising strategy for treating age-related macular degeneration.Drugs Aging 2007;24:643-62.

102) Adiel Barak, David Varssano, P. Halpern, Anat Lowenstein [ sic] .Ophthalmologists, suicide bombings and getting it right in the emergency department.Graefes Arch Clin Exp Ophthalmol 2008; 246:109-203.

103) Adiel Barak, Meira Neudorfer, Gad Heilweil, Ofer Merimsky, Anat Loewenstein , M.


Inbar, N. Yaal-Hahoshen.Decreased prevalence of asymptomatic choroidal metastasis in disseminated breast and lung cancer: argument against screening.Br J Ophthalmol 2007;91:74-5.

104) Zayit-Soudry S, Kesler A, Tsehori J, Leider-Trejo L, Loewenstein A.Ocular central nervous system lymphoma mimicking choroidal neovascularization.Ophthalmic Surg Lasers Imaging 2008;39:146-149.

105) Komarowska I, Heilweil G, Rosenfeld PJ, Perlman I, Loewenstein A.Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.Retina 2009;29:98-105.

106) Michael Waisbourd, Igal Leibovitch, Anat Loewenstein, Yuval Yassur.Lucentis versus Avastin--is there a light at the end of the tunnel for age-related macular degeneration patients?Harefuah 2008;147:605-6,662.

107) Soudry S, Zemel E, Anat Loewenstein, Perlman I.The developing mammalian retina is partially protected from gentamicin toxicity.Exp Eye Res 2009;88:1152-1160.

108) Zayit-Soudry S, Zemel E, Anat Loewenstein, Perlman I.Safety evaluation of repeated intravitreal injections of bevacizumab and ranibizumab in rabbit eyes.Retina 2010;30;671-681.

109) Burgansky-Eliash Z, Nelson DA, Bar-Tal OP, Loewenstein A, Grinvald A, Barak A.Reduced retinal blood flow velocity in diabetic retinopathy.Retina 2010; 30:765-773.

110) Michael Weisbourd, Anat Loewenstein בחסימת וריד הרזתית המרכזי[anti-VEGF]טיפול בתרופות נוגדות אנגיוגנזה

Harefuah 2010;149:243-244.

111) Heilweil G, Komarowska I, Zemel E, Loewenstein A, Perlman I.Normal physiological and pathophysiological effects of trypan blue on the retina of albino rabbits.Invest Ophthalmol Vis Sci 2010; 51:4187-4194.

112) Anat Loewenstein, Ferencz JR, Lang Y, Yeshurun I, Pollack A, Siegal R, Lifshitz T, Karp J, Roth D, Bronner G, Brown J, Mansour S, Friedman S, Michels M, Johnston R, Rapp M, Havilio M, Rafaeli O, Manor Y.Toward earlier detection of choroidal neovascularization secondary to age-related macular degeneration; Multicenter Evaluation of a Preferential Hyperacuity Perimeter Designed as a Home Device.Retina 2010; 30:1058-1064.

113) Waisbourd M, Shemesh G, Baras Top L, Lazar M, Loewenstein A.Comparison of the transpalpebral tonometer TGDc-01 with Goldmann applanation tonometry.Eur J Ophthalmol 2010; 20:902-906.


114) Mezad-Koursh D, Zayit-Soudry S, Barak A, Loewenstein A.Unilateral idiopathic macular telangiectasia with choroidal neovascularization.Ophthalmic Surg Lasers Imaging 2010 Mar 9:1-3. [Epub ahead of print]

115) Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group.Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.Ophthalmology 2010; 117:1134-1146.

116) Mezad-Koursh D, Goldstein M, Heilwail G, Zayit-Soudry S, Loewenstein A, Barak A.Clinical characteristics of endophthalmitis after an injection of intravitreal anti-vascular endothelial growth factor.Retina 2010;30:1051-1057.

117) Augustin A, Loewenstein A, Kuppermann BD.Macular edema. General pathophysiology.Dev Ophthalmol 2010;47:10-26.

118) Kuppermann BD, Loewenstein A.Drug delivery to the posterior segment of the eye.Dev Ophthalmol 2010;47:59-72.

119) Bandello F, Battaglia Parodi M, Lanzetta P, Loewenstein A, Massin P, Menchini F, Veritti D.Drug delivery to the posterior segment of the eye.Dev Ophthalmol 2010;47:73-110.

120) Loewenstein A, Zur D.Postsurgical cystoid macular edema.Dev Ophthalmol 2010;47:148-159.

121) Golan S, Loewenstein A.Steroids and the management of macular edema.Ophthalmologica 2010;224 Suppl 1:31-40.

122) Waisbourd M, Loewenstein A.The use of anti-angiogenic drugs for central retinal vein occlusion.Harefuah 2010;149:243-244,261.

123) Scholl S, Augustin A, Loewenstein A, Rizzo S, Kupperman B.General pathophysiology of macular edema.Eur J Ophthalmol. 2010;21(S6):10-19.

124) Fischer N, Narayanan R, Loewenstein A, Kuppermann BD.Drug delivery to the posterior segment of the eye.Eur J Ophthalmol. 2010;21(S6):20-26.

125) Zur D, Fischer N, Tufail A, Monés J, Loewenstein A.


Postsurgical cystoid macular edema.Eur J Ophthalmol. 2010;21(S6):62-68.

126) Klein A, Shemesh G, Loewenstein A, Kurtz S.Intraocular pressure measurements in relation to head position and through soft contact lenses: comparison of three portable instruments.Ophthalmic Surg Lasers Imaging. 2011;42(1):64-71.

127) Golan S, Shalev V, Goldstein M, Treister G, Chodick G, Loewenstein A.The rate of myocardial infarction events among patients with age-related macular degeneration: a population-based study.Graefes Arch Clin Exp Ophthalmol. 2011;249(2):179-82.

128) Moisseiev E, Kinori M, Glovinsky Y, Loewenstein A, Moisseiev J, Barak A.Retained lens fragments: nucleus fragments are associated with worse prognosis than cortex or epinucleus fragments.Eur J Ophthalmol. 2011;21(6):741-7.

129) Waisbourd M, Goldstein M, Loewenstein A.Treatment of diabetic retinopathy with anti-VEGF drugs.Acta Ophthalmol. 2011;89(3):203-7.

130) Henis O, Shahar Y, Steinvil A, Finn T, Heruti R, Loewenstein A, Justo D.Erectile dysfunction is associated with severe retinopathy in diabetic men.Urology. 2011;77(5):1133-6.

131) Coscas G, Loewenstein A, Augustin A, Bandello F, Battaglia Parodi M, Lanzetta P, Monés J, de Smet M, Soubrane G, Staurenghi G.Management of retinal vein occlusion--consensus document.Ophthalmologica. 2011;226(1):4-28.

132) Waisbourd M, Goldstein M, Loewenstein A.National survey of the ophthalmic use of anti-vascular endothelial growth factor drugs in Israel. Isr Med Assoc J. 2011 Mar;13(3):141-6.

133) Moisseiev E, Davidovitch Z, Loewenstein A, Barak A.Outcomes of epiretinal membrane removal in eyes with and without concurrent vision-limiting ocular disease.Ophthalmologica. 2011;226(2):71-5.

134) Kinori M, Moisseiev E, Shoshany N, Fabian ID, Skaat A, Barak A, Loewenstein A, Moisseiev J.Comparison of pars plana vitrectomy with and without scleral buckle for the repair of primary rhegmatogenous retinal detachment.Am J Ophthalmol. 2011;152(2):291-297.e2.

135) Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group.


Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion Twelve-Month Study Results. Ophthalmology. 2011;118(12):2453-60.

136) Zayit-Soudry S, Zemel E, Barak A, Perlman I, Loewenstein A.Safety of Intravitreal bevacizumab in the developing rabbit retina.Retina. 2011;31(9):1885-95.

137) Loewenstein A.Macular Diseases: Moving the Battlefield to the Patient's Home.Retina. 2011;31(8):1445-8.

138) Golan S, Shalev V, Treister G, Chodick G, Loewenstein A.Reconsidering the connection between vitamin D levels and age-related macular degeneration.Eye (Lond). 2011;25(9):1122-9.

139) Burgansky-Eliash Z, Barak A, Barash H, Nelson DA, Pupko O, Lowenstein A [sic], Grinvald A, Rubinstein A.Increased retinal blood flow velocity in patients with early diabetes mellitus.Retina. 2012;32:112-119.

140) Nelson DA, Burgansky-Eliash Z, Barash H, Loewenstein A, Barak A, Bartov E,Rock T, Grinvald A.High-resolution wide-field imaging of perfused capillaries without the use of contrast agent.Clin Ophthalmol. 2011;5:1095-106.

141) Spierer O, Siminovsky Z, Loewenstein A, Barak A.Outcomes of 20-gauge transconjunctival sutureless vitrectomy.Retina. 2011;31(9):1765-71.

142) Moisseiev E, Davidovitch Z, Kinori M, Loewenstein A, Moisseiev J, Barak A.Vitrectomy for idiopathic epiretinal membrane in elderly patients: surgical outcomes and visual prognosis.Curr Eye Res. 2012;37(1):50-4.

143) Barak A, Burgansky-Eliash Z, Barash H, Nelson DA, Grinvald A, Loewenstein A.The effect of intravitreal bevacizumab (Avastin) injection on retinal blood flowvelocity in patients with choroidal neovascularization.Eur J Ophthalmol. 2012;22(3):423-30.

144) Shahar J, Loewenstein A.Physiological and toxicological effects of cefuroxime on the albino rabbit retina. Invest Ophthalmol Vis Sci 2012;53(2):906-14.

145) Goldenberg D, Soiberman U, Loewenstein A, Goldstein M.Heidelberg spectral-domain optical coherence tomographic findings in retinal artery macroaneurysm Retina. 2012;32(5):990-5.

146) Goldenberg D, Habot-Wilner Z, Loewenstein A, Goldstein M.Spectral-domain optical coherence tomography classification of acuteposterior


multifocal placoid pigment epitheliopathy.Retina. 2012;32(7):1403-10.

147) Neudorfer M, Weinberg A, Loewenstein A, Barak A.Differential optical density of subretinal spaces.Invest Ophthalmol Vis Sci. 2012;53(6):3104-10.

148) Zur D, Loewenstein A.Combination therapy for diabetic macular edema.J Ophthalmol. 2012:484612.

149) Newman H, Shapira S, Spierer O, Kraus S, Rosner M, Pri-Chen S, Loewenstein A, Arber N, Barak A.Involvement of CD24 in angiogenesis in a mouse model of oxygen-induced retinopathy.Curr Eye Res. 2012;37(6):532-9.

150) Michaeli A, Soiberman U, Loewenstein A.Outcome of iris fixation of subluxated intraocular lenses.Graefes Arch Clin Exp Ophthalmol. 2012;250(9):1327-32.

151) Goldenberg D, Moisseiev E, Goldstein M, Loewenstein A, Barak A.Enhanced depth imaging optical coherence tomography: choroidal thickness and correlations with age, refractive error, and axial length.Ophthalmic Surg Lasers Imaging. 2012;43(4):296-301.

152) Loewenstein A.Use of home device for early detection of neovascular age-related macular degeneration.Ophthalmic Res. 2012;48 Suppl 1:11-5.

153) Coscas G, Zhou Q, Coscas F, Zucchiatti I, Rispoli M, Uzzan J, De Benedetto U, Savastano MC, Soules K, Goldenberg D, Loewenstein A, Lumbroso B.Choroid thickness measurement with RTVue optical coherence tomography in emmetropic eyes, mildly myopic eyes, and highly myopic eyes.Eur J Ophthalmol. 2012;22(6):992-1000.

154) Burgansky-Eliash Z, Lowenstein A [sic], Neuderfer M, Kesler A, Barash H, Nelson DA,Grinvald A, Barak A.The Correlation Between Retinal Blood Flow Velocity Measured by the Retinal Function Imager and Various Physiological Parameters.Ophthalmic Surg Lasers Imaging. 2012;10:1-8.

155) Habot-Wilner Z, Shahar J, Zemel E, Loewenstein A, Perlman I.Retinal toxicity of intravitreal rituximab in albino rabbits.Retina. 2013;33(3):649-56..

156) Moisseiev E, Goldstein M, Waisbourd M, Barak A, Loewenstein A.Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion.


Eye (Lond). 2013;27(1):65-71.

157) Mezad-Koursh D, Leibovitch I, Loewenstein A, Kurtz S.[Enlarged optic nerve head excavation in children].Harefuah. 2013;152(2):69-72, 124.

158) Goldenberg D, Goldstein M, Loewenstein A, Habot-Wilner Z.Vitreal, retinal, and choroidal findings in active and scarred toxoplasmosis lesions: a prospective study by spectral-domain optical coherence tomography.Graefes Arch Clin Exp Ophthalmol. 2013 2013;251(8):2037-45.

159) Fischer N, Moisseiev E, Waisbourd M, Goldstein M, Loewenstein A.A Matched-control comparison of serious adverse events after intravitreal Injections of bevacizumab for age-related macular degeneration and cataract extraction.Clin Ophthalmol. 2013;7:621-5.

160) Goldenberg D, Shahar J, Loewenstein A, Goldstein M.Diameters of retinal blood vessels in a healthy cohort as measured by spectral domain optical coherence tomography.Retina. 2013;33(9):1888-94

161) Burgansky-Eliash Z, Barash H, Nelson D, Grinvald A, Sorkin A, Loewenstein A, Barak A.Retinal Blood Flow Velocity in Patients with Age-Related Macular Degeneration.Curr Eye Res. 2014 Mar;39(3):304-11.

162) Moisseiev E, Waisbourd M, Ben-Artsi E, Levinger E, Barak A, Daniels T, Csaky K, Loewenstein A, Barequet IS.Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes.

Graefes Arch Clin Exp Ophthalmol. 2014;252(2):331-7.

163) Coscas G, Augustin A, Bandello F, de Smet MD, Lanzetta P, Staurenghi G,Parravano MC, Udaondo P, Moisseiev E, Soubrane G, Yatziv Y, Loewenstein A.Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol. 2014;24(1):1-9.

164) Waisbourd M, Levinger E, Varssano D, Moisseiev E, Zayit-Soudri S, Barak A, Loewenstein A, Barequet I.High-dose topical bevacizumab for corneal neovascularization.Pharmacology. 2013;92(5-6):310-4.

165) Soiberman U, Levy R, Schwartz S, Goldstein M, Loewenstein A, Barak A.Serum ischemia modified albumin and vascular endothelial growth factor levels following intravitreal bevacizumab injections.Eur J Ophthalmol. 2014; 24(4):570-575.

166) Dotan G, Goldenberg D, Kesler A, Naftaliev E, Loewenstein A, Goldstein M.The use of spectral-domain optical coherence tomography for differentiating long-standing central retinal artery occlusion and nonarteritic anterior ischemic optic neuropathy.


Ophthalmic Surg Lasers Imaging Retina. 2014;45(1):38-44.

167) Bandello F, Casalino G, Loewenstein A, Goldstein M, Pelayes D, Battaglia Parodi M. Pharmacological approach to diabetic macular edema.Ophthalmic Res. 2014;51(2):88-95.

168) Golan S, Loewenstein A.Surgical Treatment for Macular Edema.Semin Ophthalmol. 2014; 29(4):242-256.

169) Waisbourd M, Shemesh G, Kurtz S, Rachmiel R, Moisseiev E, Zayit-Soudri S, Loewenstein A, Barequet I.Topical Bevacizumab for Neovascular Glaucoma: A Pilot Study.Pharmacology. 2014;93(3-4):108-112.

170) Bar-Sela S, Fleissig E, Yatziv Y, Varssano D, Regenbogen M, Loewenstein A, Goldstein M. Long-term outcomes of triamcinolone acetonide-assisted anterior vitrectomy during complicated cataract surgery with vitreous loss.J Cataract Refract Surg. 2014; 40:722-727.

171) Soiberman U, Goldstein M, Pianka P, Loewenstein A, Goldenberg D.Preservation of the Photoreceptor Layer Following Subthreshold Laser Treatment for Diabetic Macular Edema as Demonstrated by SD-OCT.Invest Ophthalmol Vis Sci. 2014;55(5):3054-9.

172) Moisseiev E, Regenbogen M, Rabinovitch T, Barak A, Loewenstein A, Goldstein M. Evaluation of Pain During Intravitreal Ozurdex Injections Versus Intravitreal Bevacizumab Injections.Eye. 2014;28(8):83-91.

173) Sorkin N, Loewenstein A, Habot-Wilner Z, Goldstein M Intravitreal dexamethasone implant in patients with persistent macular edema of variable etiologies.Ophthalmologica. 2014;232(2):83-91.

174) Habot-Wilner Z, Sorkin N, Goldenberg D, Loewenstein A, Goldstein M.Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema.Ophthalmologica. 2014;232(2):77-82.

175) Kuppermann BD, Haller JA, Bandello F, Loewenstein A, Jiao J, Li XY, Whitcup SM. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.Retina. 2014;34:1743-1749.

176) Frenkel T, Moisseiev E, Neudorfer M, Loewenstein A, Barak A.Comparison of retinal detachment surgery outcome among patients undergoing pars plana vitrectomy with and without relaxing retinotomy.Graefes Arch Clin Exp Ophthalmol. 2015;253:855-864.


177) Golan S, Entin-Meer M, Semo Y, Maysel-Auslender S, Mezad-Koursh D, Keren G, Loewenstein A, Barak A.Gene profiling of human VEGF signaling pathways in human endothelial and retinal pigment epithelial cells after anti VEGF treatment.BMC Res Notes. 2014;7:617-624.

178) Moisseiev E, Loewenstein A.Simulation of Laser Retinopexy around Retinal Breaks for Ophthalmologists in Training.Ophthalmologica. 2015;233:51-55.

179) Adler G, Shahar J, Kesner R, Rosenfeld E, Fischer N, Loewenstein A, Kurtz S.Effect of Pupil Size on Biometry Measurements Using the IOLMaster.Am J Ophthalmol. 2015;159:940-944.

180) Dugel PU, Bandello F, Loewenstein A.Dexamethasone intravitreal implant in the treatment of diabetic macular.Clin Ophthalmol. 2015;9:1321-1335.

181) Moisseiev E, Katz G, Moisseiev J, Loewenstein A, Goldstein M, Lomnicky Y, Abend Y, Treister G, Goldenberg D, Levkovitch-Verbin H.Switching treatment for neovascular age-related macular degeneration from bevacizumab to ranibizumab: who is likely to benefit from the switch?Retina. 2015;35:1323-1330.

182) Augustin AJ, Kupperman BD, Lanzetta P, Loewenstein A, Li X-Y, Cui H. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.BMC Ophthalmol.2015 15:150-158.

183) Schwartz R, Loewenstein A.Early detection of age related macular degeneration: current status.Int J Retina Vitreous. 2015;1:20-27.

184) Moisseiev E, Loewenstein A, Yiu G.The suprachoroidal space: from potential space to a space with potential.Clin Ophthalol.2016;10:173-178.

185) Kornhauser T, Schwartz R, Goldstein M, Neudorfer M, Loewenstein A, Barak A.Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up).Graefes Arch Clin Exp Ophthalmol. 2016;254:835-844.

186) Shulman S, Goldenberg D, Schwartz R, Habot-Wilner Z, Barak A, Ehrlich N, Loewenstein A, Goldstein M.Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy.Graefes Arch Clin Exp Ophthalmol. 2016;254:15-22.

187) de Carlo TE, Rosenblatt A, Goldestein M, Baumal CR, Loewenstein A, Duker JS. Vascularization of Irregular Retinal Pigment Epithelial Detachments in Chronic Serous Chorioretinopathy Evaluated with OCT Angiography.


Ophthalmic Surg Laser Imaging Retina. 2016;47:128-133.

188) Chakravarthy U, Goldenberg D, Young G, Havilio M, Rafaeli O, Benyamini G, Loewenstein A. Automated Identification of Lesion Activity in Neovascular Age-Related Macular Degeneration.Ophthalmology. 2016; 123:1731-1736.

189) Wolf S, Bandello F, Loewenstein A, Slakter J, Katz T, Sowade O, Korobelnik . Baseline Characteristics of the Fellow Eye in Patients with Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the VIEW Studies.Ophthalmologica. 2016;236:95-99.

190) Soiberman U, Shai D, Loewenstein A, Barak A.Macular Hole Surgery with Internal Limiting Membrane-Blue versus Membrane Blue Duo: A Retrospective Comparative study.J Ophthalmol. 2016, Article ID 1292735, 6 pages.

191) Callanan DG, Loewenstein A, Patel SS, Massin P, Corcóstegui B, Li XY, Jiao J, Hashad Y, Whitcup S.A multicenter, 12-month randomized study comparing dexamethasone intravitreall implant with ranibizumab in patients with diabetic macular edema.Graefes Arch Clin Exp Ophthalmol. 2017;255:463-473.

192) Gonzalez VH, Campbell J, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ, Ma J, Ho AC, Patel V, Whitcup SM, Dugel PU.Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.Am J Ophthalmol. 2016;172:72-79.

193) Fleissig E, Barak A, Goldstein M, Loewenstein A, Schwartz S.Massive subretinal and subretinal pigment epithelial hemorrhage displacement with perfluorocharbon liquidusing a two-step vitretomy technique.Graefes Arch Clin Exp Ophthalmol. 2017;255:1341-1347.

194) Giladi M, Edri I, Goldenberg M, Newman H, Strulovich R, Khananshvili D, Haitin Y, Loewenstein APurification and characterization of human dehydrodolychil diphosphate synthase DHDDS overexpressed in Ecoli.Protein Expr Purif. 2017;132:138-142.

195) Schwartz R, Rozenberg A, Loewenstein A, Goldstein M.The relation of somatotypes and stress response to central serous chorioretinopathy.Graefes Arch Clin Exp Ophthalmol.2017;255:2307-2315.

196) Zayit-Soudry S, Vainer I, Zemel E, Mimouni M, Rabena M, Pieramici D, Loewenstein A.Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit.Doc Ophthalmol. 2017;135:175-185.


197) Habot-Wilner Z, Mazza O, Shahar J, Massarweh A, Mann I, Loewenstein A, Perlman I.Safety of intravitreal clindamycin in albino rabbit eyes.Doc Ophthalmol. 2017;134:133-146.

198) Schwartz R, Habot-Wilner Z, Martinez MR, Nutman A, Goldenberg D, Cohen S, Loewenstein A, Goldstein M.Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study.Acta Ophtalmol.2017;95:e610-e618.

199) Nemet A, Moshiri A, Yiu G, Loewenstein A, Moisseiev E.A Review of Innovations in Rhegmatogenous Retinal Detachment Surgical Techniques.J Ophthalmol. 2017, Article ID 4310643, 5 pages.

200) Lanzetta P, Loewenstein A, Vision Academy Steering Committee.Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases. Graefe's Arch Clin Exp Ophthalmol. 2017;255:1259-1273.

201) Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS, Loewenstein A.Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA).Ophthalmologica. 2017;237(4):185-222.

202) Veritti D, Sarao V, Francescutti L, Rota N, Loewenstein A, Borrelli E, Sadda S, Lanzetta P.Optical coherence tomography angiography findings in diabetic retinopathy.Expert Rev Ophthalmol. 2017;12:475-484.

203) Zur D, Iglicki M, Busch C, Inverinizzi A, Mariussi M, Loewenstein A, International Retina Group.OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema treated with Dexamethasone Implant.Ophthalmology. 2018;125:267-275.

204) Iglicki M, Busch C, Zur D, Okada M, Mariussi M, Chhablani JK, Cebeci Z, Fraser-Bell S, Chaikitmongkol V, Couturier A, Giancipoli E, Lupidi M, Rodriguez-Valdés PJ, Rehak M, Fung AT, Goldstein M, Loewenstein A.Dexamethasone implant for diabetic macular edema in naïve compared with refractory eyes: The International Retina Group Real-Life 24-month multicenter study. The IRGREL-DEX study.Retina. Ahead of Print, 2018.

205) Iglicki M, Zur D, Busch C, Okada M, Loewenstein A.Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the "DR-Pro-DEX Study".


Acta Diabetologica. 2018;55:541-547.

206) Iglicki M, Lavaque A, Ozimek M, Negri HP, Okada M, Chhablani J, Busch C, Loewenstein A, Zur D.Biomarkers and Predictors for Functional and Anatomic Outcomes for Small Gauge Pars Plana Vitrectomy and Peeling of the Internal Limiting Membrane in Naïve Diabetic Macular Edema: The VITAL Study.PLoS ONE, July 2018, https://doi.org/10.1371/journal.pone.0200365 .

207) Sarao V, Veritti D, Maurutto E, Rassu N, Borrelli E, Loewenstein A, Sadda S, Lanzetta P.Pharmacotherapeutic Management of Macular Edema in Diabetic Subjects Undergoing Cataract Surgery.Expert Opin Pharmacother. 2018;19:1551-1563.

208) Lisnayansky M, Kapelushnik N, Ben-Bassat A, Marom M, Khananshvili D, Loewenstein A, Giladi M, Haitin Y.Reduced activity of Geranylgeranyl diphodphate synthase mutant is involved in bisphosphonate-induced atypical fractures.Mol Pharmacol. 2018;94:1-10.

209) Sharma A, Reddy P, Kuppermann BD, Bandello F, Lowenstein [sic] A.Biosimilars in ophthalmology: “Is there a big change on the horizon?”Clin Ophthalmol. 201;12:2137-2143.

Case Reports

1) Anat Loewenstein, Rivka Bracha, Moshe Lazar.Intraocular lens implantation in an eye with Behcet’s uveitis.J Cataract Refract Surg 1991; 17:95-7.

2) Moshe Lazar, Anat Loewenstein, Orna Geyer.Intentional retention of Descemet’s membrane during keratoplasty.Acta Ophthalmol 1991; 69:111-2.

3) Anat Loewenstein, Orna Geyer, Yoram Biger, Ygal Shochat, Moshe Lazar.Intraocular lens in a fighter aircraft pilot.Br J Ophthalmol 1991; 75:752.

4) Ofer Merimsky, Pinchas Nisipeanu, Anat Loewenstein, Irit Reider-Grosswasser, Samario Chaitchik.Interferon-related cortical blindness.Cancer Chemother Pharmacol 1992; 29:329-30.

5) Anat Loewenstein, Yehoshua Almog, Rivka Bracha, Moshe Lazar.Spontaneous resolution of proliferative vitreoretinopathy.Acta Ophthalmol 1992; 70:549-50.

https://doi.org/10.1371/journal.pone.0200365


6) Ofer Merimsky, Anat Loewenstein, Samario Chaitchik.Cortical blindness – a catastrophic side effect of vincristine.Anticancer Drugs 1992; 3:371-3.

7) Chaim Stolovitch, Anat Loewenstein, David Varssano, Moshe Lazar.Trilateral retinoblastoma.Metab Pediatr Syst Ophthalmology 1992; 15:57-9.

8) Anat Loewenstein, Dan D. Gaton, Irit Reider-Grosswasser, Rivka Bracha, Moshe Lazar.Deformed optic chiasm and colloid cyst in a patient with visual disturbances.Metab Pediatr Syst Ophthalmol 1993; 16:9-11.

9) Anat Loewenstein, Irit Reider-Grosswasser, Dan D. Gaton, Moshe Lazar.Spontaneous thrombosis of a traumatic cavernous sinus fistula.Brain Inj 1993; 7:547-50.

10) Orna Geyer, Anat Loewenstein, Ben-Zion Garty, Moshe Lazar.Different manifestation of Rieger syndrome in monozygotic twins.J Pediatr Ophthalmol Strabismus 1994; 31:57-8.

11) Anat Loewenstein, Isaac Lipshitz, Moshe Lazar.Photorefractive keratectomy for the treatment of myopia after epikeratoplasty: a case report.J Refract Corneal Surg 1994;10:S285-6.

12) Ilan Ron, Israel Kremer, Anat Loewenstein, Samario Chaitchik.Conjunctival involvement in classic (indolent) HIV negative Kaposi’s sarcoma.Br J Ophthalmol 1994; 78:488-9.

13) David Varssano, Anat Loewenstein, Isaac Lipshitz, Rivka Bracha, Moshe Lazar.Transient cataract after scleral buckling in myopic pseudophakia.Am J Ophthalmol 1994; 117:354-5.

14) Meir Neufeld, Anat Loewenstein, Meira Neudorfer, Moshe Lazar.Opening by the Nd:YAG laser of the anterior portion of the capsular bag in the treatment of delayed onset psuedophakic endopthalmitis.a. Acta Ophthalmol 1994; 72:267-8.b. Year Book 1995, 1:2-3.

15) Anat Loewenstein, Yehoshua Almog, Moshe Lazar.Loss of accommodation as the first symptom of cataract.Am J Ophthalmol 1994;117:816-7.

16) Anat Loewenstein, Irit Rosenblatt, Yuval Yassur.Retinal toxicity caused by amiodarone.MEJO 1995; 3:119-21.

17) Yair Alster, Yehoshua Ben-Nun, Anat Loewenstein, Moshe Lazar.Pupillary block glaucoma due to residual perfluoro-decalin.


Ophthalmic Surg Lasers 1996; 27:395-6.

18) Adi Michaeli-Cohen, Yehoshua Almog, Anat Loewenstein, Isaac Gutman, Moshe Lazar.Presumed ocular myasthenia and micropsia. A case report.J Neuroophthalmol 1996; 16:18-20.

19) Anat Loewenstein, Neil Bressler.Treatment of myopic choroidal neovascularization with laser photocoagulation.The Wilmer Retina Update 2, 1996.

20) Neil Bressler, Anat Loewenstein.Juxtafoveal occult choroidal neovascularization: treatment considerations.The Wilmer Retina Update 2, 1996.

21) Anat Loewenstein, Neil BresslerBasal laminar drusen with vitelliform lesions.The Wilmer Retina Update 2, 1996.

22) Anat Loewenstein, Neil Bressler.Vitrectomy for diabetic macular edema.The Wilmer Retina Update 3, 1996.

23) Anat Loewenstein, Alon Sadeh, Yehoshua Almog, Gadi Keren, Moshe Lazar.Microangiopathy of retina & brain with hearing loss caused by cardiac emboli.Ann Ophthalmol 1997; 29:3.

24) Anat Loewenstein, Stuart McKinnon, Cathy DiBernardo.Echographic diagnosis of scleral fold in hypotony.Am J Ophthalmol 1997; 124:260-1.

25) Anat Loewenstein, Asher Winder, Michaela Goldstein, Moshe Lazar, Amiram Eldor.Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation.Am J Ophthalmol 1997; 124:840-1.

26) Yair Alster, Anat Loewenstein, David Varssano, Moshe Lazar.Delay of corneal wound healing in patients treated with colchicine.Ophthalmology 1997; 104:118-9.

27) Anat Loewenstein, Isaac Lipshitz, David Varssano, Moshe Lazar.Macular hemorrhage after excimer laser photorefractive keratectomy.J Cataract Refract Surg 1997; 23:808-10.

28) Adi Michaeli-Cohen, Meira Neudorfer, Anat Loewenstein, Moshe Lazar, Orna Geyer.Case report: visual loss caused by facial steroids.Can Fam Physician 1998; 44:2462-3.

29) Alon D Sadeh, Moshe Lazar, Anat Loewenstein.Macular ring in a patient with Terson's syndrome.Acta Ophthalmol Scand 1999; 77:599-600.


30) Anat Loewenstein, Michaela Goldstein, Aryeh Roth, Moshe Lazar.Cilioretinal artery occlusion during coronary catheterization.Acta Ophthalmol Scand 1999; 77:717-8.

31) Joseph Schwartz, Yair Alster, Ofira Ben-Tal, Anat Loewenstein.Visual loss following high-dose cytosine arabinoside (ARA-C).Eur J Haematol 2000; 64:208-9.

32) Igal Leibovitch, Michaela Goldstein, Anat Loewenstein, Adiel Barak.Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus.Rheumatology )Oxford( 2001;40:1195-6.

33) Igal Leibowich, Michaela Goldstein, Meira Neudorfer, Anat Loewenstein.Transient phacodonesis after circling buckle procedure for rhegmatogenous retinal detachment.Eye 2001;15:320-1.

34) Michaela Goldstein, Saul Merin, Moshe Lazar, Anat LoewensteinIndocyanine green angiography in diagnosis of ciliary artery occlusion.Ann Ophthalmol 2001, 33:139-140.

35) Meira Neudorfer, Igal Leibovitch, Michaela Goldstein, Anat Loewenstein.Massive choroidal hemorrhage associated with low molecular weight heparin therapy.Blood Coagul Fibrinolysis 2002;13:257-9.

36) Elizabeth Fireman, Joseph Greif, Amir Onn, Meira Neudorfer, Anat Loewenstein. Unsuspected sarcoidosis diagnosed by induced sputum in a case of isolated uveitis. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:95-6.

37) Igal Leibovitch, Barak Azmon, Pazit Pianka, Yair Alster, Anat Loewenstein.Macular hole secondary to branch retinal vein occlusion diagnosed by Retinal Thickness Analyzer.Ophthalmic Surg Lasers Imaging 2003;34:53-6.

38) Igal Leibovitch, Yair Alster, Moshe Lazar, Pazit Langevitz, Amir Livneh, Anat Loewenstein.Corneal wound healing in a patient treated with colchicines for Familial Mediterranean Fever (FMF).Rheumatology (Oxford) 2003;42:1021-2.

39) Yafa Vardizer, Yifat Linhart, Anat Loewenstein, Hana Garzozi, Nasar Mazawi, Anat Kesler.Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy.J Neuroophthalmol 2003;23:256-9.

40) Richard McDonald, Michaela Goldstein, Anat Loewenstein, Dante Pieramici, JA Khawly.Diagnostic and therapeutic challenges.


Retina 2005;25:355-9.

41) Shiri Zayit- Soudry, Meira Neudorfer, Adiel Barak, Anat Loewenstein, Edna Bash, Yardena Siegman-Igra.Endogenous Phialemonium curvatum Endophthalmitis.Am J Ophthalmol 2005;140:755-7.

42. Mezad-Koursh D, Zayit-Soudry S, Barak A, Loewenstein A.Unilateral Idiopathic Macular Telangiectasia with Choroidal Neovascularization.Ophthalmic Surg Lasers Imaging 2010 Mar 9:1-3.

REVIEW ARTICLES

Published Review Articles

1) Anat Loewenstein.Functional blinking of eye lids.Harefuah 1991; 120:237-8.

2) Anat Loewenstein, Moshe Lazar.Ocular hypotensive effect of systemic medications.Harefuah 1991; 120:732-3.

3) Anat Loewenstein.The archives attends the ISRS meeting in Minneapolis.Arch Ophthalmol 1995; 113:1236.

4) Anat Loewenstein, Eugene de Juan, Jr.Pediatric ocular trauma.Harefuah 1998; 135:469-71.

5) Alon Sadeh, Chaim Stolovitch, Eugene de Juan, Jr, Anat Loewenstein.Retinopathy of prematurity.Harefuah 1999; 136:393-9.

6) Anat Loewenstein, Julia Haller, Moshe Lazar.Biopsy of the posterior segment of the eye.Harefuah 1999; 136:574-6.

7) Yuval Yassur, Dov Weinberger, Michaela Goldstein, Anat Loewenstein.Photodynamic therapy in age-related macular degeneration.Harefuah 2000;139:220-3.

8) Anat Loewenstein, Moti Rosner, Yoram Solberg, Michael Belkin, Yuval Yassur.Passive smoking and its influence on the eye.Harefuah, 2000:139: 280-1.

9) Anat Loewenstein, Michaela Goldstein, Moshe Lazar.Retinal pathology occurring after excimer laser surgery or phakic intraocular lens


implantation: evaluation of possible relationship.Surv Ophthalmol 2002;47:125-35.

10) Shiri Zayit- Soudry, Iris Moroz, Anat Loewenstein.Retinal pigment epithelial detachment.Surv Ohthalmol 2007;52:227-43.

11)

12)

13)

Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, Eldem B, Monés J, Richard G, Bandello F. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014 Sep;98(9):1144-1167.

Dugel PU, Bandello F, Loewenstein A. Dexamethasone intravitreal implant in the treatment of diabetic macular edema. Clin Ophthalmol. 2015 Jul 16;9:1321-35.

Loewenstein A., Chkravarthy U., Bandello F.The 0.19 mg fluocinolone acetonide intravitreal implant: a review on its use in diabetic macular oedema from the Association for Research in Vision and Ophthalmology Annual Meeting 2018.European Ophthalmic Review. 2018;12: Epub ahead of print.

CHAPTERS IN BOOKS

1) Anat Loewenstein, Moshe Lazar.Drug reactions not mediated via receptors.In: (eds), Textbook of Ocular Pharmacology, Raven Press, 1997.

2) Anat Loewenstein, Neil Bressler, Susan B Bressler.Epidemiology of RPE disease.In: Marmor MF, Wolfensberger TJ (eds), Retinal Pigment Epithelium: Current Aspects of Function and Disease. New York: Oxford University Press, 1997.

3) Anat Loewenstein, Neil Bressler.Neovascular AMD.In: Guyer DR, Yannuzzi LA, Chang S, Shields J, Green WR (eds), Retina, Vitreous, Macula: A Comprehensive Text. Saunders Publishing Company, Philadelphia, PA, 1997.

4) Anat Loewenstein, Richard W. Green.Retinal histology.In: Guyer DR, Yannuzzi LA, Chang S, Shields J, Green WR (eds), Retina, Vitreous, Macula: A Comprehensive Text. Saunders Publishing Company, Philadelphia, PA, 1997.

5) Eugene de Juan Jr., Anat Loewenstein.Retinopathy of prematurity.In: Freeman (ed). A Practical Atlas of Retina.

6) Anat Loewenstein, Eugene de Juan Jr.Pediatric ocular trauma.


In: Virgil Alfaro III, Peter E. Liggett (eds). Vitreoretinal Surgery of the Injured Eye. Lippincott-Raven Publishers, Philadelphia, PA, 1999.

7) Mark S Humayun, Artyro Santos, Anat Loewenstein.Retinal detachment repair: History, principles and justification.In: Rob & Smith’s Ophthalmic Surgery, Chap. 40, 1997.

8) Mark S Humayun, Artyro Santos, Anat Loewenstein.Retinal detachment repair: Preoperative evaluation, anatomy and anesthesia.In: Rob & Smith’s Ophthalmic Surgery, Chap. 41, 1997.

9) Mark S Humayun, Artyro Santos, Anat Loewenstein.Retinal detachment repair: Operations, postoperative complications and outcomes.In: Rob & Smith’s Ophthalmic Surgery, Chap. 42, 1997.

10) Mark S Humayun, Artyro Santos, Anat Loewenstein.Vitreo-retinal surgery: History, principles and pre-operative evaluation.In: Rob & Smith’s Ophthalmic Surgery, Chap. 43, 1997.

11) Mark S Humayun, Artyro Santos, Anat Loewenstein.Vitreo-retinal surgery: Surgical instrumentation.In: Rob & Smith’s Ophthalmic Surgery, Chap. 44, 1997.

12) Mark S Humayun, Artyro Santos, Anat Loewenstein.Vitreo-retinal surgery: Anatomy, and operations.In: Rob & Smith’s Ophthalmic Surgery, Chap. 45, 1997.

13) Mark S Humayun, Artyro Santos, Anat Loewenstein.Vitreo-retinal surgery: Complications and outcomes.In: Rob & Smith’s Ophthalmic Surgery, Chap. 46, 1997.

14) Anat Loewenstein, Richard Green, Julia Haller.Chorioretinal biopsy.In: Ryans Retina.CV Mosby Co., St. Louis, Baltimore, Toronto. 3rd edition.

15) Hany S. Hamza, Anat Loewenstein, Julia Haller.Fungal retinitis and endophthalmitis.In: Ophthalmology Clinics of North America: Ocular infections: update on therapy. TP O’Brien, WB Saunders Co., Philadelphia, Pennsylvania, 1999.

16) Anat Loewenstein, Julia Haller.Transscleral diode laser retinopexy in the treatment of retinal detachment.In: Vitreoretinal Surgical Atlas.GA Peyman, Louisiana, New Orleans, 1999.

17) Jordi Monיs, Anat Loewenstein. Perimetrםa de Hiperagudeza Preferencial. In: Degeneracion Macular Asociada a la Edad. Jordi Monיs, Francisco Gomez-Ulla (eds) Editorial Prous, Barcelona, 2005.

18) Dianna Doe, Anat Loewenstein, Richard Green, Julia Haller.Vitreous, retinal and choroidal biopsy.In: Ryans Retina


CV Mosby Co., St. Louis, Baltimore, Toronto. 4th edition.

19) Michael Weisbourd, Anat LoewensteinTherapeutic monoclonal antibodies and fragments: bevacizumab.In: Retinal Pharmacotherapy. Quang Nguyen (Editor)Elsevier Ltd., London, UK

20) Anat LoewensteinRetinal detachment and lens subluxation in Marfan syndrome.In: Retinal and Choroidal Manifestations of Selected Systemic Disease. Arevalo F (Editor)Springer, in press.

21) Einat Klein, Anat Loewenstein.Avastin - pharmacologyIn: Retina Pharmacotherapy Nguyen, Rodrigues, Farah, Mieler.Elsevier, London, UKIn press.

22) Dinah Zur, Anat LoewensteinPost surgical macular edemaIn: Macular edemaKarger PublicationsIn press

23) Ainat Klein, Anat Loewenstein.Ch. 32: Therapeutic monoclonal antibodies and fragments: bevacizumab, Section 4 – Drugs and mechanisms in retinal diseases.In: Retina Pharmacotherapy (Nguyen, Rodrigues, Farah, Mieler – eds), Saunders 2010.

24) Coscas G (Ed.), Cunha-Vaz J, Anat Loewenstein, Soubrane, G. (Co-Editors).Macular Edema, A Practical Approach, Developments in Ophthalmology, Vol. 47.Karger Publications, 2010 - Elected in 2011 as "Highly Commended" by the British Medical Association

25) Coscas G (Ed.), Cunha-Vaz J, Anat Loewenstein, Soubrane, G. (Co-Editors).Oedèmes maculaires – Aspects cliniques et thérapeutiques, Collection Actualités en Opthalmologie, dirigée par le Prof. G. Coscas, Vol. 1. Springer, 2011.

26) Fischer N, Loewenstein A.Rhegmatogenous retinal detachment: Clinical preoperative and postoperative handling.In: Bandello F, Battaglia Parodi, M (Eds.).Surgical retina. (ESASO Course Series; v. 2. Selected contributions from ESASO modules 2009 and 2010) Basel: Karger, 2012; pp.99-104.

27) Klein A, Loewenstein A.Ab externo surgery of rhegmatogenous retinal detachment: handling of intraoperative and postoperative complications.In: Bandello F, Battaglia Parodi, M (Eds.).Surgical retina. (ESASO Course Series; v. 2.


Selected contributions from ESASO modules 2009 and 2010) Basel: Karger, 2012; pp.109-116.

28) Moisseiev E, Loewenstein A.Retinal detachment by giant tear or dialysis.In: Bandello F, Battaglia Parodi, M (Eds.).Surgical retina. (ESASO Course Series; v. 2. Selected contributions from ESASO modules 2009 and 2010) Basel: Karger, 2012; pp.132-135.

29) Golan S, Goldstein M, Loewenstein A. Anti VEGF Agents for Age Related Macular Degeneration, Age-Related Macular Degeneration - Etiology, Diagnosis and Management - A Glance at the Future, Dr. Giuseppe Lo Giudice (Ed.), ISBN: 978-953-51-1113-9, InTech, 2013. Available from:

30) Coscas G, Loewenstein A, Bandello F. (Eds.). Optical Coherence Tomography.(ESASO Course Series; v. 4). Basel: Karger, 2014.

31) Klein A, Loewenstein A . Therapeutic Monoclonal Antibodies and Fragments: Bevacizumab. In Dev Ophthalmol. 2016;55:232-45 Karger Publication.

32.)

33.)

34.)

35)

Zur D, Loewenstein A.Postsurgical Cystoid Macular Edema..Dev Ophthalmol. 2017;58:178-190.

Bandello F, Battaglia Parodi M, Lanzetta P, Loewenstein A, Massin P, Menchini F, Veritti D.Diabetic Macular Edema..Dev Ophthalmol. 2017;58:102-138.

Moisseiev E, Loewenstein A. Drug Delivery to the Posterior Segment of the Eye.Dev Ophthalmol. 2017;58:87-101.

Moisseiev, E., & Loewenstein, A. Diabetic Macular Edema: Emerging Strategies and Treatment Algorithms. In Management of Diabetic Retinopathy. 2017: Vol.60, pp.165-174. Karger Publishers.

OTHER PUBLICATIONS (Encyclopedias; Reports; Letter to Editors)

1) Anat Loewenstein.Tetanus in corneal injuries.Harefuah 1989; 116:450.

2) Isaac Lipshitz, Anat Loewenstein.Anaphylactic reaction following application of chloramphenicol eye ointment.Br J Ophthalmol 1991; 75:64.

3) Anat Loewenstein, Orna Geyer, Daphne Hourvitz, Moshe Lazar.The association of Fuch’s corneal endothelial dystrophy with angle closure glaucoma.Br J Ophthalmol 1991; 75:510.


4) Anat Loewenstein, Orna Geyer, Moshe Lazar.Acute glaucoma in the presence of patent neodymium YAG laser iridotomies (Correspondence).Acta Ophthalmologica 1991; 69:558.

5) Anat Loewenstein.Functional eye blinking (Correspondence).Harefuah 1991; 121:212.

6) Orna Geyer, Anat Loewenstein, Moshe Lazar.Open angle glaucoma masked by systemic medications.Arch Int Med 1991; 151:1236.

7) Anat Loewenstein, David Varssano, Roni Rahmiel, Moshe Lazar.Procurement of corneas for transplantation.Harefuah 1991; 120:317-8.

8) Anat Loewenstein, Moshe Lazar, Esther Zemel, Ido Perlman.Corticosteroid vehicle toxicity.Opthalmic Surg 1992;23:367.

9) Anat Loewenstein, Esther Zemel, Moshe Lazar, Ido Perlman.Inadvertent intravitreal corticosteroid injection (Correspondence).Ophthalmic Surg 1992; 23:367.

10) Anat Loewenstein, Moshe Lazar.Patient selection in the Timpilo StudyArch Ophthalmol 1993; 111:1313.

11) Anat Loewenstein, Orna Geyer, Moshe Lazar.Comment on "Cavernous hemangioma of the orbit" (letter + review).Eye 1993; 7.

12) Anat Loewenstein, Moshe Lazar.An all cameral IOL (Correspondence).Harefuah 1993; 124:735.

13) Anat Loewenstein, Orna Geyer, Michaela Goldstein, Moshe Lazar.Argon laser gonioplasty in the treatment of angle closure glaucoma.Acta Ophthalmol 1993; 115:399-400.

14) Alon Sadeh, Anat Loewenstein, Michaela Goldstein, Moshe Lazar.Comment on "Amaurosis fugax in young patients" (Correspondence).Br J Ophthalmol 1993; 77:464.

15) Anat Loewenstein, Moshe Lazar.Timolol-Pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma (Correspondence).Arch Ophthalmol 1993; 111:1313-1314.

16) Anat Loewenstein, Moshe Lazar.Deep lamellar keratoplasty in the treatment of bullous keratopathy


(Correspondence).Br J Ophthalmol 1993; 77:538.

17) Anat Loewenstein, Moshe Lazar.Unintentional intraocular injection of corticosteroids (Correspondence).Acta Ophthalmologica 1993; 71:717.

18) Anat Loewenstein, Orna Geyer, Michaela Goldstein, Moshe Lazar.Comment on "Angle laser gonioplasty for angle closure glaucoma unrelieved by patent iridotomy" (Correspondence).Am J Ophthalmol 1993; 115:399-440.

19) Anat Loewenstein, Moshe Lazar.Malignant glaucoma in the presence of patent iridotomy.Ophthalmolic Surg 1994; 25:554.

20) Isaac Lipshitz, Anat Loewenstein, Moshe Lazar.Comparison of excimer laser treatment of astigmatism and myopia (Correspondence).a. Arch Ophthalmol 1994; 112:1509-1510.b. Arch Ophthalmol (Edition Espanola) 1995; 6:178-179.

21) Anat Loewenstein, Daphne Hourvitz, Michaela Goldstein, Isaac Ashkenazi, Isaac Avni, Moshe Lazar.Association of Fuch’s corneal endothelial dystrophy with angle closure glaucoma (Correspondence).a. J of Glaucoma 1995; 4:221.b. J of Glaucoma 1995; 4:222.

22) Michaela Goldstein, Anat Loewenstein, Mordechai Rosner, Isaac Lipshitz, Moshe Lazar (abstract).MEJO 1995; 3:227.

23) Irit Rosenblatt, Anat Loewenstein, Moshe Lazar, Yuval Yassur.The Rotterdam Eye Study (Correspondence).Ophthalmology 1996; 196.

24) Anat Loewenstein, Orna Geyer, Moshe Lazar.Descemetotomy.J Cataract Ref Surg 1996; 22:652.

25) Pharmacological Therapy for Macular Degeneration Study Group. Interferon Alfa-2A is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration.Arch Ophthalmol 1997;115:865-872.

26) Anat Loewenstein, Moshe Lazar.Deep lamellar keratoplasty with complete removal of pathological stroma for vision improvement.Br J Ophthalmol 1998; 82:205.


27) Anat LoewensteinTo my dismay.Ophthalmology 2000; 107:228.

28) Alon D Sadeh, Irit Rosenblatt, Yakov Rosenberger, Moshe Lazar, Anat Loewenstein. Frequency and patients' reported awareness of diabetic retinopathy among type 2 diabetic patients admitted to internal medicine wards.Diabetes Care 2000; 23:1436-7.

29) Pegapanib for Neovascular Age-Related Macular Degeneration.New Engl J Med 2004; 351:2805-16.

30)

31)

Michael Waisbourd, A Rabinovitch, Gad Heilweil, Michaela Goldstein, Anat Loewenstein.Response to Dr Sanjay et al.Eye 2008 Mar 21;

Elad Moisseive and Anat Loewenstein. Management of Macular Edema. Ophthalmic Res. 2017 Mar 14.

Other Academic Activities

11th Gabriel Coscas Lecture, DMLA en Pratique, Paris France, September 9, 2013

2019.maculart-meeting.com€¦ · web viewcurricilum vitae. name. anat loewenstein, professor....

Documents